{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:05:23Z","timestamp":1790913923823,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.biocel.2008.04.007","type":"journal-article","created":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T13:25:26Z","timestamp":1208006726000},"page":"2410-2420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["2\u2032-Deoxy-4\u2032-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants"],"prefix":"10.1016","volume":"40","author":[{"given":"Atsushi","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Sarafianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kohgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.biocel.2008.04.007_bib1","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme","volume":"15","author":"Back","year":"1996","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.biocel.2008.04.007_bib2","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.01204-06","article-title":"In vitro interactions between apricitabine and other deoxycytidine analogues","volume":"51","author":"Bethell","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.biocel.2008.04.007_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00002030-199005000-00008","article-title":"The effect in vitro of 2\u2032-deoxycytidine on the metabolism and cytotoxicity of 2\u2032,3\u2032-dideoxycytidine","volume":"4","author":"Bhalla","year":"1990","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.biocel.2008.04.007_bib4","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1128\/JVI.76.18.9143-9151.2002","article-title":"Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision","volume":"76","author":"Boyer","year":"2002","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.biocel.2008.04.007_bib5","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1073\/pnas.77.11.6865","article-title":"Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo","volume":"77","author":"Carson","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.biocel.2008.04.007_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-3542(98)00025-4","article-title":"The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection","volume":"38","author":"De Clercq","year":"1998","journal-title":"Antiviral Res"},{"issue":"44","key":"10.1016\/j.biocel.2008.04.007_bib7","doi-asserted-by":"crossref","first-page":"42097","DOI":"10.1074\/jbc.M206725200","article-title":"The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues","volume":"277","author":"Deval","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.biocel.2008.04.007_bib8","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/AAC.48.5.1640-1646.2004","article-title":"Novel 4\u2032-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity","volume":"48","author":"Dutschman","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"21","key":"10.1016\/j.biocel.2008.04.007_bib9","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","article-title":"Phosphorylation of 3\u2032-azido-3\u2032-deoxythymidine and selective interaction of the 5\u2032-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.biocel.2008.04.007_bib10","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/JVI.74.8.3579-3585.2000","article-title":"The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis","volume":"74","author":"Gotte","year":"2000","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.biocel.2008.04.007_bib11","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1016\/j.bmcl.2003.07.009","article-title":"Synthesis of a highly active new anti-HIV agent 2\u2032,3\u2032-didehydro-3\u2032-deoxy-4\u2032-ethynylthymidine","volume":"13","author":"Haraguchi","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"5394","key":"10.1016\/j.biocel.2008.04.007_bib12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biocel.2008.04.007_bib13","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1128\/jvi.67.10.6224-6233.1993","article-title":"In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor","volume":"67","author":"Jeang","year":"1993","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.biocel.2008.04.007_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/095632020601700405","article-title":"A novel colorimetric assay for CXCR4 and CCR5 tropic human immunodeficiency viruses","volume":"17","author":"Kajiwara","year":"2006","journal-title":"Antivir Chem Chemother"},{"issue":"4","key":"10.1016\/j.biocel.2008.04.007_bib15","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/jvi.66.4.2232-2239.1992","article-title":"Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene","volume":"66","author":"Kimpton","year":"1992","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.biocel.2008.04.007_bib16","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/AAC.45.5.1539-1546.2001","article-title":"4\u2032-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro","volume":"45","author":"Kodama","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.biocel.2008.04.007_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1081\/NCN-120037508","article-title":"Design, efficient synthesis, and anti-HIV activity of 4\u2032-C-cyano- and 4\u2032-C-ethynyl-2\u2032-deoxy purine nucleosides","volume":"23","author":"Kohgo","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"7","key":"10.1016\/j.biocel.2008.04.007_bib18","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1128\/JVI.73.7.5356-5363.1999","article-title":"Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay","volume":"73","author":"Kosalaraksa","year":"1999","journal-title":"J Virol"},{"issue":"5224","key":"10.1016\/j.biocel.2008.04.007_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1126\/science.7542804","article-title":"Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy","volume":"269","author":"Larder","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biocel.2008.04.007_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.biocel.2008.04.007_bib21","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1073\/pnas.90.13.6135","article-title":"Mechanism of resistance of human immunodeficiency virus type 1 to 2\u2032,3\u2032-dideoxyinosine","volume":"90","author":"Martin","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.biocel.2008.04.007_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(00)80185-9","article-title":"A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase","volume":"4","author":"Meyer","year":"1999","journal-title":"Mol Cell"},{"issue":"20","key":"10.1016\/j.biocel.2008.04.007_bib23","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3\u2032-Azido-3\u2032-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"Mitsuya","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.biocel.2008.04.007_bib24","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JCM.41.6.2515-2521.2003","article-title":"Novel reporter T-cell line highly susceptible to both CCR5- and CXCR4-using human immunodeficiency virus type 1 and its application to drug susceptibility tests","volume":"41","author":"Miyake","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.biocel.2008.04.007_bib25","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/AAC.00277-07","article-title":"Activity against Human Immunodeficiency Virus Type 1, intracellular metabolism, and effects on human DNA polymerases of 4\u2032-ethynyl-2-fluoro-2\u2032-deoxyadenosine","volume":"51","author":"Nakata","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.biocel.2008.04.007_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JVI.79.2.764-770.2005","article-title":"Mutations conferring resistance to human immunodeficiency virus type 1 fusion inhibitors are restricted by gp41 and Rev-responsive element functions","volume":"79","author":"Nameki","year":"2005","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.biocel.2008.04.007_bib27","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/AAC.49.8.3355-3360.2005","article-title":"Anti-human immunodeficiency virus type 1 activity and resistance profile of 2\u2032,3\u2032-didehydro-3\u2032-deoxy-4\u2032-ethynylthymidine in vitro","volume":"49","author":"Nitanda","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.biocel.2008.04.007_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1349-7006.2001.tb01163.x","article-title":"Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides","volume":"92","author":"Obata","year":"2001","journal-title":"Jpn J Cancer Res"},{"issue":"3","key":"10.1016\/j.biocel.2008.04.007_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/tcr.20078","article-title":"2\u2032-Deoxy-4\u2032-C-ethynyl-2-fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity","volume":"6","author":"Ohrui","year":"2006","journal-title":"Chem Rec"},{"issue":"13","key":"10.1016\/j.biocel.2008.04.007_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.biocel.2008.04.007_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsb942","article-title":"Structure of human dCK suggests strategies to improve anticancer and antiviral therapy","volume":"10","author":"Sabini","year":"2003","journal-title":"Nat Struct Biol"},{"issue":"18","key":"10.1016\/j.biocel.2008.04.007_bib32","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1073\/pnas.96.18.10027","article-title":"Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids","volume":"96","author":"Sarafianos","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"51","key":"10.1016\/j.biocel.2008.04.007_bib33","doi-asserted-by":"crossref","first-page":"48466","DOI":"10.1074\/jbc.M107003200","article-title":"Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue","volume":"276","author":"Selmi","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.biocel.2008.04.007_bib34","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.92.6.2398","article-title":"Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides","volume":"92","author":"Shirasaka","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.biocel.2008.04.007_bib35","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/AAC.42.6.1484","article-title":"Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains","volume":"42","author":"Srinivas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.biocel.2008.04.007_bib36","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0021-9258(19)75738-X","article-title":"Cellular metabolism of 2\u2032,3\u2032-dideoxycytidine, a compound active against human immunodeficiency virus in vitro","volume":"262","author":"Starnes","year":"1987","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.biocel.2008.04.007_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nsmb760","article-title":"Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir","volume":"11","author":"Tuske","year":"2004","journal-title":"Nat Struct Mol Biol"},{"issue":"5253","key":"10.1016\/j.biocel.2008.04.007_bib38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.271.5253.1282","article-title":"Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase","volume":"271","author":"Wainberg","year":"1996","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.biocel.2008.04.007_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-1119(94)90641-6","article-title":"Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction","volume":"151","author":"Weiner","year":"1994","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.biocel.2008.04.007_bib40","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI4948","article-title":"A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors","volume":"102","author":"Winters","year":"1998","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.biocel.2008.04.007_bib41","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1128\/AAC.43.10.2479","article-title":"In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues","volume":"43","author":"Yoshimura","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272508001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272508001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:31:43Z","timestamp":1761201103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272508001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1357272508001490"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2008.04.007","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2\u2032-Deoxy-4\u2032-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2008.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}